577 filings
4
Arthur David J.
12 Apr 24
Salarius Pharmaceuticals / David J. Arthur ownership change
4:50pm
DEFA14A
SLRX
Salarius Pharmaceuticals Inc
26 Mar 24
Additional proxy soliciting materials
4:05pm
DEF 14A
SLRX
Salarius Pharmaceuticals Inc
Definitive proxy
26 Mar 24
4:03pm
10-K
2023 FY
SLRX
Salarius Pharmaceuticals Inc
Annual report
22 Mar 24
4:12pm
DFAN14A
SLRX
Salarius Pharmaceuticals Inc
19 Mar 24
Additional proxy materials by non-management
7:39pm
8-K
wzcji7wk
6 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
ngovjmxo2ik0yhbi92bu
22 Feb 24
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
5:55pm
4
tm8xqi1hm 6o
22 Feb 24
Salarius Pharmaceuticals / Mark J Rosenblum ownership change
4:37pm
4
usz fe2lew
22 Feb 24
Salarius Pharmaceuticals / William K. McVicar ownership change
4:29pm
4
g2mdgpb8l7h fl7
22 Feb 24
Salarius Pharmaceuticals / Bruce J Jr. McCreedy ownership change
4:25pm
4
tql1yxurlyv90t342xj
22 Feb 24
Salarius Pharmaceuticals / Jonathan I Lieber ownership change
4:21pm
4
ojgtbb
22 Feb 24
Salarius Pharmaceuticals / Paul Lammers ownership change
4:16pm
4
lvo6yyi8l
22 Feb 24
Salarius Pharmaceuticals / Tess Burleson ownership change
4:13pm
4
uhoxlsuvv3
22 Feb 24
Salarius Pharmaceuticals / ARNOLD C HANISH ownership change
4:09pm
SC 13G
615erq
14 Feb 24
Salarius Pharmaceuticals / ARMISTICE CAPITAL ownership change
3:54pm
SC 13D
16tes3db6ghc5w3
27 Oct 23
Salarius Pharmaceuticals / Lee Elvin Sanghwan ownership change
3:57pm
8-K
06ghp5pu
6 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:09pm
8-K
639k6
10 Aug 23
Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:14pm